These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic and therapeutic control of diabetogenic CD8+ T cells. Santamaria P. Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463 [Abstract] [Full Text] [Related]
4. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. Vincent BG, Young EF, Buntzman AS, Stevens R, Kepler TB, Tisch RM, Frelinger JA, Hess PR. J Immunol; 2010 Apr 15; 184(8):4196-204. PubMed ID: 20220085 [Abstract] [Full Text] [Related]
10. Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Wang Y, Martin CC, Oeser JK, Sarkar S, McGuinness OP, Hutton JC, O'Brien RM. Diabetologia; 2007 Apr 15; 50(4):774-8. PubMed ID: 17265032 [Abstract] [Full Text] [Related]
11. Idd9.2 and Idd9.3 protective alleles function in CD4+ T-cells and nonlymphoid cells to prevent expansion of pathogenic islet-specific CD8+ T-cells. Hamilton-Williams EE, Wong SB, Martinez X, Rainbow DB, Hunter KM, Wicker LS, Sherman LA. Diabetes; 2010 Jun 15; 59(6):1478-86. PubMed ID: 20299469 [Abstract] [Full Text] [Related]